Integrin inhibitors in cancer treatment

Janusz Rolski; Maciej Niemiec

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

8/2008
vol. 12

Send email

Copy url:

abstract:

Integrin inhibitors in cancer treatment

Janusz Rolski

,

Maciej Niemiec

Współczesna Onkologia (2008) vol. 12; 8 (374–379)

Online publish date: 2008/12/05

View full text Get citation

Integrins are the transmembrane proteins involved in intercellular communication and in the contact of cells with extracellular matrix. They are present in healthy and cancer cells as well. They are important in many processes: among other things, thrombosis, angiogenesis and in the metastasis of the neoplastic cells. This article summarizes current knowledge of integrin inhibitors in cancer treatment. All the available studies prove that they have the restrained toxicity and anticancer activity. Introducing them to the standard clinical practice needs further intensive studies.

keywords:

Integrin inhibitors in cancer treatment

Janusz Rolski , Maciej Niemiec

integrins, angiogenesis inhibitors, cell adhesion molecules

Janusz Rolski

,

Maciej Niemiec